These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27355624)

  • 1. Height Outcome of Recombinant Human Growth Hormone Treatment in Achondroplasia Children: A Meta-Analysis.
    Miccoli M; Bertelloni S; Massart F
    Horm Res Paediatr; 2016; 86(1):27-34. PubMed ID: 27355624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of achondroplasia with growth hormone: six years of experience.
    Ramaswami U; Rumsby G; Spoudeas HA; Hindmarsh PC; Brook CG
    Pediatr Res; 1999 Oct; 46(4):435-9. PubMed ID: 10509364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
    Li J; Wu W; Liang Y; Luo XP
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
    [No Abstract]   [Full Text] [Related]  

  • 4. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia.
    Tanaka N; Katsumata N; Horikawa R; Tanaka T
    Endocr J; 2003 Feb; 50(1):69-75. PubMed ID: 12733711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.
    Kubota T; Wang W; Miura K; Nakayama H; Yamamoto K; Fujiwara M; Ohata Y; Tachibana M; Kitaoka T; Takakuwa S; Miyoshi Y; Namba N; Ozono K
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):845-50. PubMed ID: 26814021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term recombinant human growth hormone use in Australian children with renal disease.
    Crompton CH;
    Nephrology (Carlton); 2004 Oct; 9(5):325-30. PubMed ID: 15504147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR).
    Rothenbuhler A; Esterle L; Gueorguieva I; Salles JP; Mignot B; Colle M; Linglart A
    Growth Horm IGF Res; 2017 Oct; 36():11-15. PubMed ID: 28822957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis.
    Massart F; Miccoli M; Baggiani A; Bertelloni S
    Pharmacogenomics; 2015 Nov; 16(17):1965-73. PubMed ID: 26555758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy.
    Rodari G; Cattoni A; Albanese A
    J Endocrinol Invest; 2020 Feb; 43(2):209-217. PubMed ID: 31452114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment improves final height and nutritional status of children with chronic kidney disease and growth deceleration.
    Bizzarri C; Lonero A; Delvecchio M; Cavallo L; Faienza MF; Giordano M; Dello Strologo L; Cappa M
    J Endocrinol Invest; 2018 Mar; 41(3):325-331. PubMed ID: 28819753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth over 10 years following a 1-year trial of growth hormone therapy.
    Rees L; Ward G; Rigden SP
    Pediatr Nephrol; 2000 Apr; 14(4):309-14. PubMed ID: 10775075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiation.
    Rogol AD; Cohen P; Weng W; Kappelgaard AM; Germak JA
    Horm Res Paediatr; 2013; 80(1):28-37. PubMed ID: 23816571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT; Eklöf O; Ivarsson S; Aronson S; Westphal O; Sipilä I; Kaitila I; Bland J; Veimo D; Müller J; Mohnike K; Neumeyer L; Ritzen M; Hagenäs L
    Acta Paediatr; 2005 Oct; 94(10):1402-10. PubMed ID: 16299871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
    Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
    Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature.
    Wong SC; Hassan K; McGrogan P; Weaver LT; Ahmed SF
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1315-24. PubMed ID: 18341091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable Growth Hormone Treatment Response in a Young Boy with Achondroplasia.
    Krstevska-Konstantinova M; Stamatova A; Gucev Z
    Med Arch; 2016 Apr; 70(2):148-50. PubMed ID: 27147792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.